Olivero Lorenzo, Sinclair Jorge, Singh Trisha, Khanijo Aditya A, Mundhra Gunjan, Chindris Ana-Maria, Menser Terri, Franco Pablo Moreno, Pollock Benjamin D, Chirila Razvan M
Department of Critical Care, Mayo Clinic, Jacksonville, FL.
Department of Internal Medicine, Jacobi Medical Center, New York, NY.
Mayo Clin Proc Innov Qual Outcomes. 2024 Sep 6;8(5):475-479. doi: 10.1016/j.mayocpiqo.2024.08.001. eCollection 2024 Oct.
This study investigated the accuracy of mortality attributions assigned by the US News and World Report (USNWR) to the diabetes and endocrinology specialty. We reviewed medical records of all consecutive Medicare fee-for-service inpatients at Mayo Clinic, Florida (Jacksonville, Florida) with a Medicare Severity Diagnosis Related Group included in the USNWR Diabetes & Endocrinology specialty cohort admitted from November 2018 to April 2022, with documented mortality in our institution's electronic health record within 30 days of the index admission. A clinician adjudicated the primary cause of death, categorizing it as diabetes or endocrine, cancer, failure to thrive, or other. Among 49 deceased patients, only 7 (14.3%) had diabetes or an endocrine-related cause of death. Cancer (49.0%) and failure to thrive (30.6%) were the leading causes. This substantial discrepancy (86% misattribution) suggests USNWR's methodology might not precisely reflect the quality of care, potentially misleading patients and impacting hospital rankings.
本研究调查了《美国新闻与世界报道》(USNWR)对糖尿病和内分泌专科的死亡率归因准确性。我们回顾了佛罗里达州梅奥诊所(佛罗里达州杰克逊维尔)所有连续的医疗保险按服务收费住院患者的病历,这些患者的医疗保险严重程度诊断相关组被纳入USNWR糖尿病与内分泌专科队列,于2018年11月至2022年4月入院,且在我们机构的电子健康记录中有索引入院后30天内记录的死亡情况。一名临床医生判定主要死因,将其归类为糖尿病或内分泌、癌症、发育不良或其他。在49名死亡患者中,只有7名(14.3%)有糖尿病或内分泌相关的死因。癌症(49.0%)和发育不良(30.6%)是主要死因。这种巨大差异(86%的归因错误)表明USNWR的方法可能无法准确反映医疗质量,可能误导患者并影响医院排名。